Related Experiment Videos
Future prospects for implantable devices for atrial defibrillation.
1Cardiology Division, Department of Medicine, The University of Hong Kong, 19/F, Block K, Queen Mary Hospital, Pokfulam Road, Hong Kong, China.
Cardiology Clinics
|March 5, 2004
Summary
Implantable devices for atrial fibrillation (AF) are evolving, combining pacing and cardioversion to prevent and treat AF. These safe devices significantly decrease AF incidence and improve quality of life.
Area of Science:
- Cardiology
- Biomedical Engineering
- Electrophysiology
Background:
- The success of implantable cardioverter defibrillators (ICDs) inspired the development of implantable devices for atrial fibrillation (AF).
- Implantable AF devices are rapidly evolving, integrating pacing and cardioversion for prevention and treatment.
Purpose of the Study:
- To review the current state and future potential of implantable devices for terminating atrial fibrillation.
- To highlight the safety and efficacy of these devices in managing AF.
Main Methods:
- Review of recent studies and clinical data on implantable AF devices.
- Analysis of device capabilities combining pacing and cardioversion therapies.
Main Results:
- Current implantable AF devices are safe and effective.
- These devices significantly reduce AF incidence and enhance patient quality of life.
- Recent studies demonstrate significant improvements in quality of life.
Conclusions:
- Implantable devices for atrial defibrillation are poised to play a larger role in managing AF.
- Combination therapy with ICDs and cardiac resynchronization therapy is particularly beneficial where AF is common.